Immune-Inflammatory markers and heart failure incidence and mortality: a population-based longitudinal study - Quiz - MDSpire

Immune-Inflammatory markers and heart failure incidence and mortality: a population-based longitudinal study

  • By

  • Siqi Li

  • Jie Cai

  • Feiyang Zhao

  • Liangkai Chen

  • Xia Han

  • Xue Xiao

  • Hui Xiong

  • Jinfeng Yang

  • June 11, 2026

  • 0 min

Share

Original Source(s)

Immune-Inflammatory markers and heart failure incidence and mortality: a population-based longitudinal study

  • by Siqi Li, Jie Cai, Feiyang Zhao, Liangkai Chen, Xia Han, Xue Xiao, Hui Xiong, Jinfeng Yang

  • June 11, 2026

Related Content

Pulsed field ablation vs. medical therapy for atrial fibrillation: a propensity score–matched comparison with the JoFib registry

How Quickly Are Patients Reaching Quadruple HFrEF Therapy?

Delays in initiating guideline-directed quadruple therapy may increase early clinical risk in heart failure with reduced ejection fraction.

Soluble fms-like tyrosine kinase-1 and peripartum cardiomyopathy: an exploratory meta-analysis of association and diagnostic performance